Current Signal Transduction Therapy
Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
  |
Contents
Current Signal Transduction Therapy, Volume 6 - Number 1
Putative Breast Tumor Suppressor TACC2 Suppresses the Aggressiveness of Breast Cancer Cells through a PLCγ Pathway
, 6(1): 55 - 64Shan Cheng, Tracey A. Martin, Xu Teng and Wen G. Jiang
DOI: 10.2174/157436211794109361
Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)
, 6(1): 65 - 70Jens R. Larsen, Morten Smerup, Rikke Norregaard, Jane H. Christensen, Kim Sivesgaard, Sara D. Christensen, Karin Christensen, Erik Sloth, Peter Torp, Niels Gregersen and J. Michael Hasenkam
DOI: 10.2174/157436211794109406
Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
, 6(1): 71 - 81Hiroki Hagiwara and Kiichiro Matsumura
DOI: 10.2174/157436211794109424
Balance Between S6K-S6 and 4E-BP1 Depends on ERK Activity in Developing Neurons
, 6(1): 82 - 87Ichiro Nishimura, Kanji Mori, Yoshitaka Matsusue, Hidetoshi Okabe and Tokuhiro Chano
DOI: 10.2174/157436211794109343
Serine-Threonine Protein Kinases CK1, CK2 and GSK3 in Normal and Malignant Haematopoiesis
, 6(1): 88 - 98Francesco Piazza, Sabrina Manni, Anna Colpo, Laura Quotti Tubi, Carmela Gurrieri and Gianpietro Semenzato
DOI: 10.2174/157436211794109370
Dasatinib in the Treatment of Chronic Myeloid Leukemia
, 6(1): 99 - 105Joanna Gora-Tybor and Tadeusz Robak
DOI: 10.2174/157436211794109352
Molecular Mechanisms of Action of Gas1 and its Possible Therapeutic Applications
, 6(1): 106 - 112Gabriela Dominguez-Monzon, Ricardo Gonzalez-Ramirez and Jose Segovia
DOI: 10.2174/157436211794109433
Identification of Phosphoproteins and their Impact as Biomarkers in Cancer Therapeutics
, 6(1): 113 - 140Samantha M. Frawley Cass and Jetze J. Tepe
DOI: 10.2174/157436211794109389
Editor-in-Chief
Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
The University of Oklahoma Health Science Center
Oklahoma City, OK
Biography
Biography of Jingxuan Yang
Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.
Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net